Name
ariadne.ai ag
What We Do
ariadne.ai ag is the technology leader in spatial omics data analysis, accelerating drug discovery for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. As a contract research organization (CRO), we provide cutting-edge computational solutions for drug and target discovery using spatial omics experiments.
Our expertise spans:
1. Advanced spatial omics data analysis for drug discovery and disease characterization.
2. Custom AI-driven image analysis pipelines tailored to spatial transcriptomics and proteomics.
3. Automated and scalable cloud-based solutions for high-throughput spatial biology studies.
4. Expert consulting on experimental design, data integration, and multimodal spatial analytics.
Our flagship platform, SPATIAL, is a cloud-based spatial biology analysis suite that streamlines the entire workflow—from raw data preprocessing to statistical analysis. SPATIAL supports all spatial omics modalities, including 3D and multi-omics experiments.
Our expertise spans:
1. Advanced spatial omics data analysis for drug discovery and disease characterization.
2. Custom AI-driven image analysis pipelines tailored to spatial transcriptomics and proteomics.
3. Automated and scalable cloud-based solutions for high-throughput spatial biology studies.
4. Expert consulting on experimental design, data integration, and multimodal spatial analytics.
Our flagship platform, SPATIAL, is a cloud-based spatial biology analysis suite that streamlines the entire workflow—from raw data preprocessing to statistical analysis. SPATIAL supports all spatial omics modalities, including 3D and multi-omics experiments.
Website
Categories (8)
Analysis, Bioinformatics, Contract Research Organization, Data Analysis Software, Data Management, Data Sharing, Image Analysis and Processing, Research Services
First Time Exhibitor
First Time Exhibitor
Address
Buchrain, Luzern
Switzerland
Switzerland